Part
01
of one
Part
01
HealthTech Unicorns
Tempus, a US-based genomics and data analytics company, raised $100 million in a Series G round on March 13, 2020. This round brings the company's total valuation to $5 billion. The website, country, date of the last funding round, size/amount (USD) of the last funding round, type of the last funding round, and valuation of the identified healthtech unicorns have been provided in A-HealthTech Unicorns List tab of the attached spreadsheet overview of the findings can be found below.
- Ginkgo BioWorks raised $70 million in its latest Series E round held on May 28, 2020.
- According to CB Insights, Ginkgo BioWorks is valued at $4.2 billion.
- Insightec raised $150 million in its latest Series F funding round held on March 6, 2020. The company has a post-money valuation of $1.3 billion.
Research Note
The date, size/amount, and type of the last funding round was found using industry databases, excluding Crunchbase. This information was then corroborated by at least 1-2 news and media articles. In addition, from the initially identified unicorns, 6 companies including Miaoshou, Modernizing Medicine, Proteus Digital Health, Weiyi, eClinicalWorks, and DNAnexus, were replaced with other healthtech unicorns because sufficient, credible, and/or recent information on their unicorn status was not found. Proteus Digital Health was removed and replaced as it recently filed for bankruptcy. These companies were replaced with HeartFlow, Ginkgo BioWorks, Butterfly Network, Oxford Nanopore Technologies, Clover Health, and Insightec to complete the list of 28 healthtech unicorns.